A Randomized, Phase III Trial Comparing CPT-11/ Cisplatin with Etoposide/Cisplatin in Patients with Previously Untreated, Extensive Small-Cell Lung Cancer

Abstracts/Posters/Presentations:

• A Sandler, C Langer, P Bunn, L Einhorn A Randomized Phase III Trial Comparing CPT-11 (Irinotecan HCl; Camptosar Injection)/Cisplatin with Etoposide/Cisplatin in Patients with Previously Untreated, Extensive, Small-Cell Lung Cancer: A Hoosier Oncology Group Study LUN00-12. Poster presentation at the ASCO annual meeting May 31-June 3, 2003, Chicago, IL
• A Sandler, C Langer, P Bunn, L Einhorn. Interim Safety Analysis of Irinotecan and Cisplatin Combination Chemotherapy for Previously Untreated Extensive Small Cell Lung Cancer LUN00-12. Accepted to the ASCO annual meeting May 13-17, 2005 in Orlando, Florida

Manuscripts/Articles:

• Hanna N, Bunn PA Jr, Langer C, Einhorn L, Guthrie T Jr, Beck T, Ansari R, Ellis P, Byrne M, Morrison M, Hariharan S, Wang B, Sandler A. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol. 2006 May 1;24(13):2038-43. See abstract.